Kazuo Takayama, Ryosuke Negoro, Fuminori Sakurai, Masashi Tachibana, Hiroyuki Mizuguchi (Graduate School of Pharmaceutical Sciences, Osaka University)

Seiichi Ishida, Shinichiro Horiuchi, Shoko Uchida, Yukie Kuroda, Su-Ryang Kim, Yuko Sekino (Division of Pharmacology, National Institute of Health Science)

Motohiro Suzuki, Hiroshi Hasegawa, Minoru Tsuda, Yoshihiro Konno, Masahiro Nomoto, Satoru Ishii, Masahiro Satsukawa, Seiji Tanaka, Yasunori Kawakita, Kazuhiro Taniyama, Yuuya Houjyou, Hiroyuki Kakuo, Syunji Kuribayashi, Sigeru Furuta, Shin-ichi Miura (Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA))

Bi Jing ¹, Kento Nishida ¹, Rui Fujimura ¹, Tadashi Imafuku ¹, Yuna Tominaga ¹, Hiroshi Watanabe ^1,2, Masaki Otagiri ³, Toru Maruyama ^1,2 (1.Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Japan, 2.Center for Clinical Pharmaceutical Sciences, School of Pharmacy, Kumamoto University, Japan, 3.Faculty of Pharmaceutical Sciences, Sojo University, Japan)

Kenji Tsukigawa ^1,2, Hideaki Nakamura ^1,3, Jun Fang ^1,3, Masaki Otagiri ^1,3, Hitoshi Maeda ³ (1.Faculty of Pharmaceutical Sciences, Sojo University, 2.Department of Pharmaceutical Sciences, Kyushu University of Health and Welfare, 3.DDS Research Institute, Sojo University)